Taiwan FDA registration a13d080795c3c71cf3214eaea7940a8d
"AEON" Glucose Control solution (Non-Sterile)
TW: "長青"葡萄糖品管液(未滅菌)
Taiwan·Risk Class 1·MD·AEON DIAGNOSTIC TECHNOLOGY CORPORATION·Registered Nov 13, 2017 – Nov 13, 2027ActiveRegistration details
- Analysis ID
- a13d080795c3c71cf3214eaea7940a8d
- License Form
- Ministry of Health Medical Device Manufacturing No. 007015
Company information
- Manufacturer
- AEON DIAGNOSTIC TECHNOLOGY CORPORATION
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- AEON DIAGNOSTIC TECHNOLOGY CORPORATION
Product details
- Intended Use
- Limited to the first level identification range of quality control materials (analytical and non-analytical) (A.1660) of the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Nov 13, 2017
- Expiry Date
- Nov 13, 2027
About this record
Access comprehensive regulatory information for "AEON" Glucose Control solution (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number a13d080795c3c71cf3214eaea7940a8d and manufactured by AEON DIAGNOSTIC TECHNOLOGY CORPORATION. The authorized representative in Taiwan is AEON DIAGNOSTIC TECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices